Jun 14 – A number of biotech stocks got hit last month when a controversial paper was released throwing doubt on the new and extremely promising gene-editing technique called CRISPR. Ian Haydon, a doctoral student at the University...
Sign up today to listen to this full podcast and gain unlimited access to premium content.